BioViva USA, Inc.
Gene therapy company that treats diseases and aging at the cellular level… with a potential solution to Alzheimer’s Disease and Atherosclerosis. Human clinical trials are scheduled.
We are committed to creating regenerative medicine to alleviate diseases caused by cellular degeneration and genetic disorders. We focus on aging, as this is the common root of most major diseases.
We bring these treatments to the clinic for both compassionate and consensual use and to change how we treat disease in the future.
Products / Services
Gene therapies for major aging-related disease and conditions
BioViva offers potential single treatment cures and vaccines for Alzheimer’s Disease, atherosclerosis and sarcopenia and will begin human clinical trials in 2015.
Aging is a complex process that inevitably leads to disease and dysfunction and this is why we are targeting our therapies to treat it to head disease off at the pass. These are some of our immediate targets to develop gene therapies for, and this will develop as we develop new ways to treat illness and learn more about aging:
* Lengthen Telomeres
* Reverse Atherosclerosis
* Clear Misfolded Proteins
* Clear Senescent Cells
* Re-strengthen Muscles
* Re-boot the immune System
* Improve Cell Signaling
* Treat Monogenic Disease